Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Business dual listing

Nutex Health Dual-Listing on Nasdaq Texas

Analysis based on 6 articles · First reported Sep 22, 2026 · Last updated Sep 23, 2026

Sentiment
5
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The dual listing is a minor, company-specific capital-markets event with negligible broader market impact, though it modestly improves Nutex Health's liquidity and regional investor visibility. Market reaction is likely to be limited given the listing is administrative in nature and does not change the company's fundamentals or capital structure.

healthcare financial exchanges

Nutex Health Inc. (NASDAQ: NUTX) announced on Sept. 22, 2026 that it received approval to dual-list its common stock on Nasdaq Texas. Trading on the Nasdaq Texas venue is expected to commence at the market open on or about Sept. 23, 2026. The company's common stock will continue to trade on the Nasdaq Global Market under its current ticker symbol NUTX. The dual listing does not require any action by existing stockholders, and shares will remain fully fungible across both trading venues. In connection with the dual listing, Nutex Health filed a registration statement on Form 8-A with the United States — United States Securities and Exchange Commission under Section 12(b) of the Securities Exchange Act of 1934. Chairman and CEO Tom Vo said the move expands the company's visibility among regional institutional investors while maintaining the national and international presence of its primary Nasdaq market. Nutex Health is a physician-led healthcare services and operations company headquartered in Houston, Texas, founded in 2011, with 28 hospital facilities in 12 states and a primary care-centric, risk-bearing physician network. It operates through three divisions: Hospital, Population Health Management, and Real Estate.

90 Nutex Health received approval to dual-list Nasdaq
stock
Nutex Health is the central actor, receiving approval to dual-list its common stock on Nasdaq Texas and filing a Form 8-A registration statement with the SEC. The move modestly broadens its investor base and liquidity without altering its capital structure.
Importance 100.0 Sentiment 10.0
exch
Nasdaq, through its Nasdaq Texas venue, approved the dual listing of Nutex Health's common stock, adding a regional listing to its exchange footprint.
Importance 60.0 Sentiment 5.0
govactor
The SEC received Nutex Health's Form 8-A registration statement filed under Section 12(b) of the Securities Exchange Act of 1934 in connection with the dual listing.
Importance 30.0 Sentiment 0.0
per
Tom Vo, Chairman and CEO of Nutex Health, commented that the dual listing expands the company's visibility among regional institutional investors while maintaining its national and international Nasdaq presence.
Importance 25.0 Sentiment 5.0
Nasdaq regulated exchange ↔ United States — United States Securities and Exchange Commission Nasdaq operates as a national securities exchange under the direct regulatory oversight of the U.S. Securities and Excha
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.